Cargando…

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival

We conducted the present study to evaluate the frequency and prognostic importance on long-term survival of TP53 mutations and TP53 protein accumulation in a cohort of 178 patients with early-stage ovarian carcinomas. TP53 mutations scored as aberrant temporal temperature gradient gel electrophoresi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Y, Helland, Å, Holm, R, Skomedal, H, Abeler, V M, Danielsen, H E, Tropé, C G, Børresen-Dale, A-L, Kristensen, G B
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Molecular and Cellular Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410156/ https://www.ncbi.nlm.nih.gov/pubmed/14760384 http://dx.doi.org/10.1038/sj.bjc.6601537

Ejemplares similares

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.
por: Skomedal, H., et al.
Publicado: (1995)

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer
por: Kupryjańczyk, J, et al.
Publicado: (2004)

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen
por: Kupryjańczyk, J, et al.
Publicado: (2003)

Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway
por: Joshi, H, et al.
Publicado: (2012)

TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva
por: Rolfe, K J, et al.
Publicado: (2003)

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
por: Helland, A., et al.
Publicado: (1998)

Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones
por: Kraus, I, et al.
Publicado: (2004)

Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status.
por: Smith-Sørensen, B., et al.
Publicado: (1998)

A prospective study of the relationship between prediagnostic Human Papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas
por: Sigstad, E, et al.
Publicado: (2002)

Characterisation of p53 status at the gene, chromosomal and protein levels in oesophageal adenocarcinoma
por: Doak, S H, et al.
Publicado: (2003)

Detection of p53 mutations in precancerous gastric tissue
por: Morgan, C, et al.
Publicado: (2003)

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer
por: Kelsey, K T, et al.
Publicado: (2004)

p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients
por: Bonnefoi, H, et al.
Publicado: (2002)

p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer
por: Fondevila, C, et al.
Publicado: (2004)

Collagen crosslink excretion and staging of oral cancer
por: Springer, I N G, et al.
Publicado: (2003)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck
por: Fouret, P, et al.
Publicado: (2002)

Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation
por: Dent, J, et al.
Publicado: (2003)

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma
por: Lassus, H, et al.
Publicado: (2004)

An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation
por: Cascinu, S, et al.
Publicado: (2002)

The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients
por: de Manzoni, G, et al.
Publicado: (2002)

Detection of human papillomavirus-16 in ovarian malignancy
por: Wu, Q-J, et al.
Publicado: (2003)

Experience with International Neuroblastoma Staging System and Pathology Classification
por: Ikeda, H, et al.
Publicado: (2002)

The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system
por: Burns, A S Y W, et al.
Publicado: (2002)

Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer
por: Ahmed, N, et al.
Publicado: (2004)

Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma
por: Rosenthal, A N, et al.
Publicado: (2003)

Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours
por: Yoshida, T, et al.
Publicado: (2004)

Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
por: Pelosi, G, et al.
Publicado: (2003)

Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage
por: Pardo, F S, et al.
Publicado: (2004)

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma
por: Yokoyama, Y, et al.
Publicado: (2003)

Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer
por: Akahira, J-i, et al.
Publicado: (2004)

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma
por: Weichert, W, et al.
Publicado: (2004)

Proliferation and aneusomy predict survival of young patients with astrocytoma grade II
por: Wessels, P H, et al.
Publicado: (2003)

Dominant negative knockout of p53 abolishes ErbB2-dependent apoptosis and permits growth acceleration in human breast cancer cells
por: Huang, G C, et al.
Publicado: (2002)

Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells
por: Zhang, X, et al.
Publicado: (2004)

Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis
por: Tebeu, P-M, et al.
Publicado: (2004)

Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb
por: Hitchings, A W, et al.
Publicado: (2004)

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker
por: Hoffman, B R, et al.
Publicado: (2002)

Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
por: Michalides, R, et al.
Publicado: (2002)

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer
por: Goffin, J R, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_ertu8hag5dvos7ti3390uv93bl